trimethylamine has been researched along with Liver Cirrhosis in 3 studies
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Excerpt | Relevance | Reference |
---|---|---|
"Liver fibrosis is one main histological characteristic of nonalcoholic steatohepatitis (NASH), a disease paralleling a worldwide surge in metabolic syndromes with no approved therapies." | 1.72 | Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis. ( Ding, BS; Mo, C; Xiao, C; Zhang, J; Zhou, D, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Zhou, D | 1 |
Zhang, J | 1 |
Xiao, C | 1 |
Mo, C | 1 |
Ding, BS | 1 |
Ryu, SD | 1 |
Yi, HG | 1 |
Cha, YN | 1 |
Kang, JH | 1 |
Kang, JS | 1 |
Jeon, YC | 1 |
Park, HK | 1 |
Yu, TM | 1 |
Lee, JN | 1 |
Park, CS | 1 |
Marks, R | 1 |
Dudley, F | 1 |
Wan, A | 1 |
3 other studies available for trimethylamine and Liver Cirrhosis
Article | Year |
---|---|
Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis.
Topics: Animals; Disease Models, Animal; Gastrointestinal Microbiome; Liver Cirrhosis; Methylamines; Mice; N | 2022 |
Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation.
Topics: Adult; Ascorbic Acid; Carcinoma, Hepatocellular; Dithiothreitol; Enzyme Inhibitors; Hepatitis B, Chr | 2004 |
Trimethylamine metabolism in liver disease.
Topics: Choline; Chronic Disease; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Methylamines | 1978 |